Royce & Associates’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.5M Buy
472,316
+44,844
+10% +$3.22M 0.33% 72
2026
Q1
$24.3M Buy
427,472
+68,931
+19% +$4.71M 0.24% 111
2025
Q4
$26.1M Buy
358,541
+69,766
+24% +$4.21M 0.27% 108
2025
Q3
$11.8M Sell
288,775
-111,688
-28% -$4.56M 0.12% 259
2025
Q2
$17.1M Buy
400,463
+207,972
+108% +$7.25M 0.18% 177
2025
Q1
$7.85M Buy
192,491
+86,965
+82% +$3.24M 0.09% 347
2024
Q4
$4.86M Buy
+105,526
New +$4.6M 0.05% 486
2024
Q2
Sell
-15,625
Closed -$795K 892
2024
Q1
$795K Sell
15,625
-565
-3% -$22.7K 0.01% 747
2023
Q4
$419K Buy
+16,190
New +$474K ﹤0.01% 800

Other funds holding ESTA

Royce & Associates's ESTA Position: Q2 2026 in Review

Royce & Associates increased its Establishment Labs (ESTA) stake by 10% in Q2 2026, buying an estimated $3.22M and bringing the position to 472,316 shares worth $40.5M. The position accounts for 0.33% of the portfolio, ranked #72.

Royce & Associates first reported a position in ESTA in Q4 2023 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold ESTA as of Q2 2026.

  • Royce & Associates held 472,316 shares of Establishment Labs worth $40.5M as of Q2 2026.
  • Royce & Associates bought 44,844 Establishment Labs shares in Q2 2026, an estimated $3.22M.
  • Establishment Labs made up 0.33% of Royce & Associates's portfolio in Q2 2026, its #72 holding.
  • Royce & Associates first reported a position in Establishment Labs in Q4 2023 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held Establishment Labs as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.